News
  • About Us
  • Test serviecs
  • Regulations
  • R & D Service
  • News
  • Contact Us
  • Congratulations to Rainbowlabs for passing the CNAS inspecti

    2015-06-16 15:26:42
    Congratulations to Rainbowlabs for passing the CNAS inspecti
    A good news came that Rainbow Labs passed the site assessment of China National Accreditation Service for Conformity Assessment (CNAS) on November 9, 2014. At present, CNAS is the unique and most authoritative laboratory accreditation certification body. Being approved by CNAS, proves that our level and capacity are up to international standard, product inspection result reliable. The certificate or report issued by us, will be recognized by 56 countries in a mutual recognition system.

    Since then, Rainbow Labs becomes a laboratory which is approved and qualified by the US FDA, Health Canada and CNAS China at the same time. We will constantly make intensified effort on international registration and mutual recognition, unswervingly adhere to the strategy of quality innovation combined with the international high-end market access.
  • comments list

    [ManuelTum  2023-10-03 17:48]  Seriously a good deal of awesome information. write my paper for cheap write paper for me paper writing service kindergarten writing paper buy research paper research paper services research proposal cover page online proposal theses dissertations https://essaywriting4you.com
    [Samsefly  2023-10-03 17:43]  where can i buy clomid online safely
    [Ashsefly  2023-10-03 16:18]  where can i buy accutane online
    [Shaenwrido  2023-10-03 13:17]  You actually expressed that very well. pay for research paper paper writing service custom papers pay for papers
    [Ivysefly  2023-10-03 13:14]  37.5 mg zoloft
    Total 34993/35209 Pages Frist Prev Prev10  34991   34992  34993  34994   34995   34996   34997   34998   34999   35000  Next10 Next Last

    I want to comment

    content*
    Your name
    Verify code* 
  • Go Top
Shijiazhuang Rainbowlabs pharmaceutical Technology Co. Ltd  Copyright